Literature DB >> 1351753

Loss of heterozygosity on chromosome 16 in hepatocellular carcinoma.

K Sakai1, H Nagahara, K Abe, H Obata.   

Abstract

In order to understand the molecular genetics of human hepatocellular carcinoma (HCC) a common chromosomal abnormality in HCC was examined using restriction fragment length polymorphism (RFLP) analysis. Sixty-eight HCC specimens were examined for loss of heterozygosity at 11 different chromosomal arms including 1p, 5p, 11p, 11q, 13q, 14q, 15q, 16p, 16q, 18q, and 19q. Losses were not detected on chromosome 1, 5, 14, 15 or 19, and the frequencies of losses were low (11-19%) for chromosomes 11, 13 and 18. In contrast, loss of heterozygosity was frequently observed for three different loci on chromosome 16, the HBA locus at 16p13.3 (22%), the MT2 locus at 16q21-22.1 (15%) and the HP locus at 16q22.1-22.2 (39%). There was no remarkable difference in the frequencies of loss of heterozygosity at these loci among HBV related HCC, HCV related HCC and neither virus (NBNC) related HCC. Thus, the results indicate that at least three different genetic abnormalities in chromosome 16 are commonly observed in various HCC, and that this chromosome may have some important role(s) in recessive genetic changes which generate this tumour.

Entities:  

Mesh:

Year:  1992        PMID: 1351753     DOI: 10.1111/j.1440-1746.1992.tb00982.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate.

Authors:  L Gramantieri; D Trerè; A Pession; F Piscaglia; L Masi; S Gaiani; A Mazziotti; L Bolondi
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

2.  Expression of p300 and CBP is associated with poor prognosis in small cell lung cancer.

Authors:  Yina Gao; Jingshu Geng; Xuan Hong; Jiping Qi; Yang Teng; Yang Yang; Di Qu; Gongyan Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

3.  HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML.

Authors:  L Zhou; V R Ruvolo; T McQueen; W Chen; I J Samudio; O Conneely; M Konopleva; M Andreeff
Journal:  Leukemia       Date:  2012-12-18       Impact factor: 11.528

4.  Transcriptional deregulation of the keratin 18 gene in human colon carcinoma cells results from an altered acetylation mechanism.

Authors:  Philippe Prochasson; Cécile Delouis; Olivier Brison
Journal:  Nucleic Acids Res       Date:  2002-08-01       Impact factor: 16.971

5.  Expression of HDAC1 and CBP/p300 in human colorectal carcinomas.

Authors:  Katsuyoshi Ishihama; Mitsunori Yamakawa; Shuho Semba; Hiroaki Takeda; Sumio Kawata; Seishi Kimura; Wataru Kimura
Journal:  J Clin Pathol       Date:  2007-08-24       Impact factor: 3.411

Review 6.  Emerging roles of E2Fs in cancer: an exit from cell cycle control.

Authors:  Hui-Zi Chen; Shih-Yin Tsai; Gustavo Leone
Journal:  Nat Rev Cancer       Date:  2009-11       Impact factor: 60.716

7.  TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation.

Authors:  Iok In Christine Chio; Masato Sasaki; Danny Ghazarian; Juan Moreno; Susan Done; Takeshi Ueda; Satoshi Inoue; Yu-Ling Chang; Nien Jung Chen; Tak Wah Mak
Journal:  Nat Cell Biol       Date:  2012-05-06       Impact factor: 28.824

8.  Dietary fat/cholesterol-sensitive PKCβ-RB signaling: Potential role in NASH/HCC axis.

Authors:  Wei Huang; Devina Mehta; Said Sif; Lindsey N Kent; Samson T Jacob; Kalpana Ghoshal; Kamal D Mehta
Journal:  Oncotarget       Date:  2017-05-15

9.  The prognostic capacities of CBP and p300 in locally advanced rectal cancer.

Authors:  Felix Rühlmann; Indra Maria Windhof-Jaidhauser; Cornelius Menze; Tim Beißbarth; Hanibal Bohnenberger; Michael Ghadimi; Sebastian Dango
Journal:  World J Surg Oncol       Date:  2019-12-19       Impact factor: 2.754

10.  Whole-genome sequencing of single circulating tumor cells from neuroendocrine neoplasms.

Authors:  Alexa Childs; Christopher D Steele; Clare Vesely; Francesca M Rizzo; Leah Ensell; Helen Lowe; Pawan Dhami; Heli Vaikkinen; Tu Vinh Luong; Lucia Conde; Javier Herrero; Martyn Caplin; Christos Toumpanakis; Christina Thirlwell; John A Hartley; Nischalan Pillay; Tim Meyer
Journal:  Endocr Relat Cancer       Date:  2021-08-11       Impact factor: 5.678

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.